Veregen sinecatechins regulatory update

MediGene said 17 European countries issued positive opinions for approval of MAAs for Veregen to treat genital warts, Germany acted as the reference member state under the mutual recognition procedure. The company said "within the next months" it expects a decision for the territories, where it plans to begin launching the product by year end. The countries include Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Greece, Hungary, Luxembourg, the Netherlands, Norway, Poland, Romania, Slovakia, Slovenia and Sweden. ...